rxstatShortages › Indomethacin

Indomethacin shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Indomethacin products are in shortage in Canada (3 of 7 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 10, 2026.

An anti-inflammatory (NSAID) used to relieve pain and inflammation from arthritis and gout.

Products affected
3 / 7
In shortage since
Mar 10, 2017
Est. full return
Oct 10, 2026
Reports on file
14
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TEVA-INDOMETHACIN
50MG · CAPSULE · TEVA CANADA LIMITED
DIN 00337439 · since Feb 18, 2026, est. end Oct 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO INDOMETHACIN CAP 25MG
25MG · CAPSULE · APOTEX INC
DIN 00611158 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO INDOMETHACIN CAP 50MG
50MG · CAPSULE · APOTEX INC
DIN 00611166 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Resolved
TEVA-INDOMETHACIN
50MG · CAPSULE · TEVA CANADA LIMITED
DIN 00337439 · ended Oct 29, 2025 · Disruption of the manufacture of the drug.
Resolved
ODAN-INDOMETHACIN
100MG · SUPPOSITORY · ODAN LABORATORIES LTD
DIN 02231800 · ended Jun 30, 2025 · Disruption of the manufacture of the drug.
Discontinued
AURO-INDOMETHACIN
50MG · CAPSULE · AURO PHARMA INC
DIN 02499223
Resolved
TEVA-INDOMETHACIN
25MG · CAPSULE · TEVA CANADA LIMITED
DIN 00337420 · ended Jun 8, 2023 · Disruption of the manufacture of the drug.
Discontinued
SANDOZ INDOMETHACIN
50MG · SUPPOSITORY · SANDOZ CANADA INCORPORATED
DIN 02231799
Resolved
SANDOZ INDOMETHACIN
50MG · SUPPOSITORY · SANDOZ CANADA INCORPORATED
DIN 02231799 · ended Apr 18, 2023 · Disruption of the manufacture of the drug.
Discontinued
SANDOZ INDOMETHACIN
100MG · SUPPOSITORY · SANDOZ CANADA INCORPORATED
DIN 02231800
Resolved
SANDOZ INDOMETHACIN
100MG · SUPPOSITORY · SANDOZ CANADA INCORPORATED
DIN 02231800 · ended Apr 4, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-INDOMETHACIN
25MG · CAPSULE · TEVA CANADA LIMITED
DIN 00337420 · ended Apr 14, 2021 · Disruption of the manufacture of the drug.

Showing 12 of 14 reports. All reports are on file with Health Canada.

What's happening

Indomethacin is currently affected by 3 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Indomethacin is classified under “ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS” (ATC M01AB).

Recent changes

Common questions

What is Indomethacin used for?

An anti-inflammatory (NSAID) used to relieve pain and inflammation from arthritis and gout.

When will Indomethacin be back in stock in Canada?

The latest manufacturer estimate is Oct 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Indomethacin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antiinflammatory/antirheumatic prod.,non-steroids)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.